New look – same great service!
We are a CADD company focused on combining cutting edge technology and science, with exceptional personalized research services. We call our approach RaaS: Research as a Service; it was time for our branding to reflect our forward-thinking mission.
Welcome to our new operations coordinator, Justin Buschman-Dormond! Justin has a Bachelor of Business Administration from Bishop's University and will use his management and planning skills to help our team be effective and efficient in our day-to-day and longer-term activities.
Ben got his https://t.co/AVS2sP0wsY. with honours from @Carleton_U and will focus his work on developing #machinelearning tools for therapeutic and molecular design applications. Welcome to the team, Ben!
We are growing! Today, we are thrilled to announce that we are adding Benjamin Weiser to our team. As part of a @MitacsCanada grant, Ben is starting his Ph.D. with us at MFI and and at @mcgillu.
#growth#startups#teambuilding
Combining NMX’s biophysics platform and structural knowledge with MFI’s #CADD expertise and tools will help accelerate the preclinical stages of #drugdiscovery by feeding each company’s workflows with the other’s skills.
MFI: https://t.co/rbnU99LkI4
NMX: https://t.co/HjxpoDFYWz
[#Partnership]
Today, we are thrilled to announce the new partnership between MFI and NMX Research and Solutions Inc!
To learn more about what we will achieve together as #partners, go check out our announcement: https://t.co/4r2KGaLliK
Psst. Guess what? MFI’s got a new website! We’re excited for you to visit and let us know what you think!
➡️ info: https://t.co/s4xFztJBHV
🌐 homepage: https://t.co/rbnU99LSxC
📰 newsletter signup: https://t.co/BRey8fiO7k
This year marks the 20th anniversary of the conference, which highlights advances in current and emerging “hot” targets and technologies for the discovery and development of novel #therapeuticagents. Registration is still open: https://t.co/rvNDTaoPtQ
#DOT2023#BostonDOT2023
Our CEO .@JPottel, will attend the #DiscoveryOnTarget conference in Boston (09/25-09/27). His poster, titled “The Synergy of Computational and Experimental Approaches in #DrugDesign: A Muscarinic Receptor Case Study”, showcases the utility of combining #experiment and #simulation
Josh will be available to meet throughout the days to discuss #CADD, to explain how we can support your #research, and to showcase why we make a great collaborator for #biotech, #pharma, and other service providers/CROs.
📅 Save the Date! Exciting news for all #Biotech enthusiasts! 🧪🔬
📍Location: Montréal
🗓️Date: August 26-27
Join us at InVitro 2023 Biotech conference! 🌐 This event aims to foster collaboration and drive #innovation in the #biotechnology industry. 🚀
Attend workshops, showcases, and panels to gain valuable insights into #biotech trends and developments. 📚 Don't miss the chance to network with professionals from #academia, #industry, #bioeconomics, and #bioethics! 🤝
📚 [#FITTED User Report] Exciting collaborative work from multiple departments at the University of Pécs 🏛️, Budapest University of Technology and Economics, and University of Debrecen on the binding modes of polysulfides in the Transient Receptor Potential Ankyrin 1 (#TRPA1) 🧪
🎓🎉 Congratulations to Antoine Moitessier, our talented intern, on graduating with a Bachelor's in #Pharmacology form @mcgillu! We are excited to have him join our team full-time before pursuing his graduate studies.
#Graduation#Pharmacology#CareerJourney
[#teambuilding] As scientists, we have learned that breakthroughs emerge as we combine our imagination and practicality. Two weeks ago, we took a refreshing approach to inspiring #innovation, to building #teamwork, and to nurturing our creativity and our collaborative mindset.
[#teambuilding] As scientists, we have learned that breakthroughs emerge as we combine our imagination and practicality. Two weeks ago, we took a refreshing approach to inspiring #innovation, to building #teamwork, and to nurturing our creativity and our collaborative mindset.